Table 1.
Variable | Patients with CD (n = 25) | Health donors (non‐IBD; n = 16) |
---|---|---|
Age mean (SD) | 40.32 (17.1) | 30.69 (8.66) |
Sex (%) | ||
Female | 12 (48) | 8 (50) |
Male | 13 (52) | 8 (50) |
Treatment at time of appointment (%) | ||
6MP/azathioprine | 1 (4) | |
Azathioprine + Pentasa + prednisone | 2 (8) | |
Asacol | 1 (4) | |
Humira + methotrexate | 1 (4) | |
Pentasa | 1 (4) | |
Azathioprine | 2 (8) | |
Humira | 4 (16) | |
Prednisone | 2 (8) | |
Infliximab + azathioprine | 1 (4) | |
Humira + azathioprine | 1 (4) | |
Cholestyramine | 1 (4) | |
Adalimumab + azathioprine | 1 (4) | |
No medication | 7 (28) |